CYP2C19 and ischemic stroke: To test whether the effect of CYP2C19 LoF genotypes on ischaemic stroke risk was specific to clopidogrel, and not via a separate but unknown biological mechanism, we analysed the 198 868 UK Biobank participants with general practitioner (GP) prescribing data in whom clopidogrel was never prescribed (see figure 1).